STADA Arzneimittel Aktiengesellschaft (ETR:SAZ – Get Free Report) shot up ∞ on Tuesday . The stock traded as high as €80.98 ($88.99) and last traded at €80.40 ($88.35). 92,068 shares traded hands during mid-day trading, an increase of 78% from the average session volume of 51,761 shares.
STADA Arzneimittel Aktiengesellschaft Trading Up ∞
The stock has a fifty day moving average price of €80.40 and a 200-day moving average price of €80.40.
About STADA Arzneimittel Aktiengesellschaft
STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidin Naloxone for pain; Atorvastatin for elevated cholesterol levels; Epoetin zeta for anemia; Diclofenac for pain/inflammation; and Pantoprazole for gastric ulcer/reflux.
Featured Stories
- Five stocks we like better than STADA Arzneimittel Aktiengesellschaft
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to Capture the Benefits of Dividend Increases
- Insider Buying Signals Upside for These 3 Stocks
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for STADA Arzneimittel Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STADA Arzneimittel Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
